Comparison of biochemical response during antiviral treatment in patients with chronic hepatitis B infection.
Si Ho KimEun Ju ChoBoo Ok JangKyunghan LeeJae Kyun ChoiGwang Hyeon ChoiJeong-Hoon LeeSu Jong YuYun Joon KimYun Bin LeeJeong-Hwan YoonJin-Wook KimSook-Hyang JeongEun Sun JangPublished in: Liver international : official journal of the International Association for the Study of the Liver (2021)
In real-world practice, ETV was preferable for older, hepatitis B e-antigen negative patients with underlying comorbidities. Biochemical responses in patients treated with ETV, TAF, and TDF were significantly affected by metabolic factors such as fatty liver, obesity, and DM. However, the mechanism behind the higher biochemical response rate in patients treated with ETV should be investigated further.